New insights into conditions for new blood vessel formation
7/07/2014
Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is essential to the body's development.
Adipose-derived stem cells resist chemo drug
7/06/2014
In lab tests, Brown University researchers have found that adipose-derived stem cells, which can generate bone tissue, appear resistant to the toxicity of the chemotherapy drug methotrexate, which...
Potential new treatment for aggressive breast cancer
7/06/2014
Early-stage research offers hope that a treatment could be developed against breast cancer tumors that fail to respond to the first-line drug Herceptin.
In a bizarre twist, Cyclin D, long believed to promote cancer, actually activates tumor suppressor
7/06/2014
Researchers at the University of California, San Diego School of Medicine say a protein essential to regulating cell cycle progression - the process of cell division and replication - activates a key...
Study links high cholesterol to increased risk of breast cancer
7/06/2014
In a study of UK women, researchers find that those with high cholesterol may be at higher risk of developing breast cancer than women with normal cholesterol levels.
Mortality of hemodialysis patients considerably reduced by antibiotic therapy
7/06/2014
An antibiotic therapy known to reduce catheter-related bloodstream infections in hemodialysis patients has been shown for the first time to reduce mortality, according to a Henry Ford Health System...
Lung cancer patients could benefit from new non-invasive advanced image analysis
7/05/2014
Lung cancer patients could receive more precise treatment, and their progress could be better tracked, using a new high-tech method of non-invasive medical imaging analysis, according to a study...
Purdue-designed tool helps guide brain cancer surgery
7/04/2014
A tool to help brain surgeons test and more precisely remove cancerous tissue was successfully used during surgery, according to a Purdue University and Brigham and Women's Hospital study.
From 3 July 2014, Halaven® (eribulin) is licenced in the UK for the treatment of patients with locally advanced or metastatic breast cancer (MBC) who have progressed after at least one...
Sickle cell drug passes early phase trial
7/04/2014
A potentially groundbreaking investigational drug designed to treat the painful vaso-occlusive crises that are the hallmark of sickle cell disease has been found to be safe following a clinical...